MICHAEL CAMPBELL: Open Payments
NPI 1669684460 · HONESDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 16 payments from 6 companies in 2025. Trend: 2023 $367 · 2024 $305 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $160 |
| Indivior Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Sage Therapeutics, LLC | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: REXULTI, SUBLOCADE, ABILIFY MAINTENA, FANAPT, ZURZUVAE, AUSTEDO XR, UZEDY, INGREZZA.
Industry payments across PA — which companies pay providers there.
